We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Alternating Antibiotics Eliminate Drug-Resistant Bacteria

By HospiMedica International staff writers
Posted on 20 Apr 2015
Print article
Image: Scanning electron micrograph (SEM) of Escherichia coli, rod-shaped bacteria, which were grown in a culture (Photo courtesy of US National Institute of Allergy and Infectious Diseases).
Image: Scanning electron micrograph (SEM) of Escherichia coli, rod-shaped bacteria, which were grown in a culture (Photo courtesy of US National Institute of Allergy and Infectious Diseases).
A new technique has been pioneered to help combat the rise of antibiotic-resistant bacteria that cause debilitating and often life-threatening human illness.

The technique uses sequential treatments, alternating doses of antibiotics which might offer effective treatment against bacterial infection. This technique demonstrates that by administering sequential treatment also reduces the risk of the bacteria becoming resistant to antibiotics, and so maintaining the long-term effectiveness of the drugs.

Scientists at the University of Exeter (UK) working with colleagues in Mexico and Germany showed that sequential treatments can clear the bacterium when the equivalent combination treatment fails to, provided, that is, that the drugs are deployed in a suitably optimized, sequential manner. To demonstrate this, they used the following laboratory system: Escherichia coli K12 (AG100) was targeted with two antibiotics, erythromycin (a macrolide, ERY) and doxycycline (a tetracycline, DOX), that bind to different ribosomal RNA subunits, thereby inhibiting translation. While this is a nonclinical drug pairing, the commercial drug Synercid (comprising quinupristin and dalfopristin) also targets ribosomal RNA combinatorially.

After increasing dosages to their 70% inhibitory concentration (IC70) values, the following evidence of bacterial clearance by 96 hours was observed. Sixteen sequential treatments that produced some of the lowest population densities after 96 hours of treatment were examined, and, using spot tests, no live cells could be isolated for five of these treatments in all three replicates. In order to determine genetic changes due to the differential stresses found in drug-free conditions and in the sequential and combination treatments, two treatments at half maximal inhibitory concentration (IC50) that produced comparable densities at 96 hour were subjected to a whole-genome sequencing analysis and compared to the drug-free populations. All replicate populations from 24 hours and 96 hours were sequenced using the paired end technology on the ABI 7500 real time polymerase chain reaction system machine (Applied Biosystems; Grand Island, NY, USA).

Robert Beardmore, PhD, a professor and lead author of the study, said, “Our study finds a complex relationship between dose, bacterial population densities and drug resistance. As we demonstrate, it is possible to reduce bacterial load to zero at dosages that are usually said to be sub lethal and, therefore, are assumed to select for increased drug resistance.” The study was published on April 8, 2015, in the journal Public Library of Science Biology.

Related Links:

University of Exeter 
Applied Biosystems 


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Digital Radiography Generator
meX+20BT lite

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.